<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03618095</url>
  </required_header>
  <id_info>
    <org_study_id>S2354</org_study_id>
    <nct_id>NCT03618095</nct_id>
  </id_info>
  <brief_title>REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects</brief_title>
  <acronym>REPRISE IV</acronym>
  <official_title>REPRISE IV: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of LOTUS Edge Valve System in IntermediatE Surgical Risk Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      REPRISE IV: REpositionable Percutaneous Replacement of Stenotic Aortic Valve through&#xD;
      Implantation of LOTUS Edge Valve System in IntermediatE Surgical Risk Subjects&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate safety and effectiveness of the LOTUS Edge™ Valve System when used with the&#xD;
      Lotus™ or iSleeve™ Introducer Sets for transcatheter aortic valve replacement (TAVR) in&#xD;
      symptomatic subjects with severe aortic stenosis who are considered at intermediate risk for&#xD;
      surgical valve replacement including those who have a bicuspid native valve.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Investigational Medical Device is no longer available&#xD;
  </why_stopped>
  <start_date type="Actual">January 14, 2019</start_date>
  <completion_date type="Actual">March 31, 2021</completion_date>
  <primary_completion_date type="Actual">March 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Evaluation of Lotus Edge to treat patients with aortic stenosis. A single intervention is being evaluated in 3 study arms, the roll-in, main and bicuspid cohorts.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of all-cause mortality and all stroke.</measure>
    <time_frame>1 year post index procedure and device implantation</time_frame>
    <description>Critical safety events that are observed in the elderly population undergoing TAVR; assessments recommended by VARC</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">382</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Main Cohort</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcatheter Aortic Valve Replacement (TAVR) with the LOTUS Edge Valve System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Roll-In Cohort</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcatheter Aortic Valve Replacement (TAVR) with the LOTUS Edge Valve System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bicuspid Cohort</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcatheter Aortic Valve Replacement (TAVR) with the LOTUS Edge Valve System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LOTUS Edge Valve System</intervention_name>
    <description>TAVR with the LOTUS Edge Valve System</description>
    <arm_group_label>Bicuspid Cohort</arm_group_label>
    <arm_group_label>Main Cohort</arm_group_label>
    <arm_group_label>Roll-In Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject has documented severe aortic stenosis defined as initial AVA ≤1.0 cm2 (or AVA&#xD;
             index ≤0.6 cm2/m2) AND a mean pressure gradient ≥40 mm Hg OR maximal aortic valve&#xD;
             velocity ≥4.0 m/s OR Doppler velocity index ≤0.25 as measured by echocardiography&#xD;
             and/or invasive hemodynamics. Note: In cases of low flow, low gradient aortic stenosis&#xD;
             with left ventricular dysfunction (ejection fraction &lt;50%), dobutamine can be used to&#xD;
             assess the grade of aortic stenosis (maximum dobutamine dose of 20 mcg/kg/min&#xD;
             recommended)c; the subject may be enrolled if echocardiographic criteria are met with&#xD;
             this augmentation. (IC1)&#xD;
&#xD;
          -  A subject in the Bicuspid Aortic Valve Nested Registry cohort must have a documented&#xD;
             Sievers Type 0 or Sievers Type 1 bicuspid aortic valve based on CT assessment and&#xD;
             confirmed by the CT core lab with hemodynamic parameters that meet the criteria in&#xD;
             IC1.&#xD;
&#xD;
          -  Subject has a documented aortic annulus size of ≥20 mm and ≤27 mm based on the&#xD;
             center's assessment of pre-procedure diagnostic imaging (and confirmed by the Case&#xD;
             Review Committee [CRC]).&#xD;
&#xD;
          -  Subject has symptomatic aortic valve stenosis per IC1 definition above with NYHA&#xD;
             Functional Class ≥ II.&#xD;
&#xD;
          -  Heart team (which must include an experienced cardiac interventionalist and an&#xD;
             experienced cardiac surgeon) agrees that the subject is at intermediate risk of&#xD;
             operative mortality (≥3% and &lt;8% at 30 days based on the Society of Thoracic Surgeons&#xD;
             [STS] risk score and other clinical comorbidities unmeasured by the risk calculator)&#xD;
             and TAVR is appropriate. Note: Risk of operative mortality must be assessed via an&#xD;
             in-person evaluation by a center cardiac surgeon and must be confirmed by the CRC&#xD;
             (which must include an experienced cardiac surgeon).&#xD;
&#xD;
          -  Heart team agrees that the subject is likely to benefit from valve replacement. IC7.&#xD;
             Subject (or legal representative) has been informed of the study requirements and the&#xD;
             treatment procedures, and provides written informed consent.&#xD;
&#xD;
          -  Subject, family member, and/or legal representative agree(s) and subject is capable of&#xD;
             returning to the study hospital for all required scheduled follow-up visits.&#xD;
&#xD;
          -  Subject is expected to be able to take the protocol-required adjunctive pharmacologic&#xD;
             therapy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has a unicuspid or bicuspid aortic valve (not applicable to subjects in the&#xD;
             Bicuspid Nested Registry cohort).&#xD;
&#xD;
          -  Subjects in the Bicuspid Nested Registry cohort will have a documented Sievers Type 0&#xD;
             or Sievers Type 1 bicuspid aortic valve based on CT assessment and confirmed by the CT&#xD;
             core lab. Subjects are not eligible for inclusion in the Bicuspid Nested Registry&#xD;
             cohort if the maximum diameter of the ascending aorta is &gt;45 mm or if the subject has&#xD;
             another indication for aortic root replacement. Subjects with a Sievers Type 2&#xD;
             bicuspid valve are not eligible for enrollment in any study cohort.&#xD;
&#xD;
          -  Subject has had an acute myocardial infarction within 30 days prior to the index&#xD;
             procedure (defined as Q-wave MI or non-Q-wave MI with total CK elevation ≥ twice&#xD;
             normal in the presence of CK-MB elevation and/or troponin elevation).&#xD;
&#xD;
          -  Subject has had a cerebrovascular accident or transient ischemic attack clinically&#xD;
             confirmed by a neurologist or neuroimaging within the past 6 months prior to study&#xD;
             enrollment.&#xD;
&#xD;
          -  Subject is on renal replacement therapy or has GFR &lt;20 (based on hospital preferred&#xD;
             method). See AEC1 below if subject is in the CT Imaging Substudy.&#xD;
&#xD;
          -  Subject has a pre-existing prosthetic aortic or mitral valve.&#xD;
&#xD;
          -  Subject has severe (4+) aortic, tricuspid, or mitral regurgitation.&#xD;
&#xD;
          -  Subject has moderate to severe mitral stenosis (mitral valve area ≤1.5 cm2 and&#xD;
             diastolic pressure half-time ≥150 ms, Stage C or Dc).&#xD;
&#xD;
          -  Subject has a need for emergency surgery for any reason.&#xD;
&#xD;
          -  Subject has a history of endocarditis within 6 months of index procedure or evidence&#xD;
             of an active systemic infection or sepsis.&#xD;
&#xD;
          -  Subject has echocardiographic evidence of new intra-cardiac vegetation or&#xD;
             intraventricular or paravalvular thrombus requiring intervention.&#xD;
&#xD;
          -  Subject has platelet count &lt;50,000 cells/mm3 or &gt;700,000 cells/mm3, or white blood&#xD;
             cell count &lt;1,000 cells/mm3.&#xD;
&#xD;
          -  Subject will refuse transfusions or has had a gastrointestinal bleed requiring&#xD;
             hospitalization or transfusion within the past 3 months, or has other clinically&#xD;
             significant bleeding diathesis or coagulopathy that would preclude treatment with&#xD;
             required antiplatelet regimen.&#xD;
&#xD;
          -  Subject has known hypersensitivity to contrast agents that cannot be adequately&#xD;
             pre-medicated, or has known hypersensitivity to aspirin, all P2Y12 inhibitors,&#xD;
             heparin, nickel, tantalum, titanium, or polyurethanes.&#xD;
&#xD;
          -  Subject has a life expectancy of less than 24 months due to non-cardiac, comorbid&#xD;
             conditions based on the assessment of the investigator at the time of enrollment.&#xD;
&#xD;
          -  Subject has hypertrophic cardiomyopathy.&#xD;
&#xD;
          -  Subject has any therapeutic invasive cardiac or vascular procedure within 30 days&#xD;
             prior to the index procedure (except for balloon aortic valvuloplasty or pacemaker or&#xD;
             implantable cardioverter defibrillator implantation, which are allowed).&#xD;
&#xD;
          -  Subject has multivessel coronary artery disease with a Syntax score &gt;22, and/or an&#xD;
             unprotected left main coronary artery.&#xD;
&#xD;
          -  Subject has severe left ventricular dysfunction with ejection fraction &lt;20%.&#xD;
&#xD;
          -  Subject is in cardiogenic shock or has hemodynamic instability requiring inotropic&#xD;
             support or mechanical support devices.&#xD;
&#xD;
          -  Subject has arterial access that is not acceptable for the study device delivery&#xD;
             system as defined in the device Instructions For Use.&#xD;
&#xD;
          -  Subject has severe vascular disease that would preclude safe access (e.g., aneurysm&#xD;
             with thrombus that cannot be crossed safely; marked tortuosity; significant narrowing&#xD;
             of the abdominal aorta; severe unfolding of the thoracic aorta; or thick, protruding,&#xD;
             ulcerated atheroma in the aortic arch).&#xD;
&#xD;
          -  Subject has current problems with substance abuse (e.g., alcohol, etc.) that may&#xD;
             interfere with the subject's participation in this study.&#xD;
&#xD;
          -  Subject is participating in another investigational drug or device study that has not&#xD;
             reached its primary endpoint.&#xD;
&#xD;
          -  Subject has untreated conduction system disorder (e.g., Type II second degree&#xD;
             atrioventricular block) that in the opinion of the treating physician is clinically&#xD;
             significant and requires a pacemaker implantation. Enrollment is permissible after&#xD;
             permanent pacemaker implantation.&#xD;
&#xD;
          -  Subject has severe incapacitating dementia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher U. Meduri, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Piedmont Heart Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vinod H. Thourani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Piedmont Heart Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Huntsville Hospital</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tucson Medical Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Heart Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mills-Peninsula Medical Center - Sutter Health</name>
      <address>
        <city>Burlingame</city>
        <state>California</state>
        <zip>94010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>USC Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Hospital</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medstar Heart and Vascular Institute</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JFK Medical Center</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>33462</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Florida Regional Medical Center</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AdventHealth Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellstar Research Institute</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University Health - Methodist Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Via Christi Hospital</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charlton Memorial Hospital - Southcoast Health</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health - Grand Rapids</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiac &amp; Vascular Research Center of Northern Michigan</name>
      <address>
        <city>Petoskey</city>
        <state>Michigan</state>
        <zip>49770</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Cloud Hospital</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Englewood Hospital</name>
      <address>
        <city>Englewood</city>
        <state>New Jersey</state>
        <zip>07631</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Winthrop Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center/NewYork Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novant Health Heart &amp; Vascular Institute - Charlotte</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UNC Rex Hospital</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Lindner Center for Research and Education</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence St. Vincent Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Memorial Hospital - Prisma Health</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centennial Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann - Texas Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas - Memorial Hermann Southwest</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White The Heart Hospital</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Annandale</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>WVU Heart &amp; Vascular Institute</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Froedtert Hospital - Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monash Cardiovascular Research Centre</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>August 1, 2018</study_first_submitted>
  <study_first_submitted_qc>August 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2018</study_first_posted>
  <last_update_submitted>July 28, 2021</last_update_submitted>
  <last_update_submitted_qc>July 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The data and study protocol for this clinical trial may be made available to other researchers in accordance with the Boston Scientific Data Sharing Policy (http://www.bostonscientific.com/en-US/data-sharing-requests.html).</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

